Pseudomonas aeruginosa: Difference between revisions
From IDWiki
Pseudomonas aeruginosa
No edit summary |
(→) |
||
| Line 19: | Line 19: | ||
== Treatment == |
== Treatment == |
||
| − | * |
+ | * Refer to [[antipseudomonal antibiotics]] for specific treatment options |
* Double coverage (ß-lactam + non-ß-lactam) in cases of severe infection in order to ensure activity against the infection |
* Double coverage (ß-lactam + non-ß-lactam) in cases of severe infection in order to ensure activity against the infection |
||
Revision as of 11:07, 24 October 2019
Background
Microbiology
- Oxidase-positive, non-fermenting Gram-negative bacillus
Mechanisms of Resistance
- Broad intrinsic and acquired antibiotic resistance
- Membrane impermeability
- MexAB-OprM efflux pump
- Acquired mutations
- Inducible AmpC β-lactamase
- Plasmid sharing
Epidemiology
- Loves moist and wet environments
- Causes healthcare-associated infections
- UTI, SSI, bacteremia, HAP, VAP
- Especially common in cystic fibrosis
Treatment
- Refer to antipseudomonal antibiotics for specific treatment options
- Double coverage (ß-lactam + non-ß-lactam) in cases of severe infection in order to ensure activity against the infection
References
- ^ D. M. Livermore. Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?. Clinical Infectious Diseases. 2002;34(5):634-640. doi:10.1086/338782.
